NCT05007041View on ClinicalTrials.gov

Simultaneous RZV and aIIV4 Vaccination

PHASE4CompletedINTERVENTIONAL
Enrollment

267

Participants

Timeline

Start Date

September 21, 2021

Primary Completion Date

March 4, 2023

Study Completion Date

June 8, 2023

Conditions
PainQuality of LifeInjection Site ReactionAdverse Drug Event
Interventions
BIOLOGICAL

FLUAD® Quadrivalent

Advisory Committee on Immunization Practices (ACIP) Recommended Vaccine

BIOLOGICAL

Fluzone® High-Dose Quadrivalent

Advisory Committee on Immunization Practices (ACIP) Recommended Vaccine

BIOLOGICAL

SHINGRIX®

Advisory Committee on Immunization Practices (ACIP) Recommended Vaccine

Trial Locations (2)

21218

Johns Hopkins University, Baltimore

27710

Duke University, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

Johns Hopkins University

OTHER

lead

Duke University

OTHER